A carregar...
Double-Blind, Randomized Study Evaluating the Glycemic and Anti-inflammatory Effects of Subcutaneous LY2189102, a Neutralizing IL-1β Antibody, in Patients With Type 2 Diabetes
OBJECTIVE: Inflammation is associated with pancreatic β-cell apoptosis and reduced insulin sensitivity. Literature suggests that interleukin (IL)-1β may contribute to the pathogenesis of type 2 diabetes mellitus (T2DM). This study aimed to determine the efficacy, safety, and tolerability of LY218910...
Na minha lista:
Main Authors: | , , , , , , , |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
American Diabetes Association
2013
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3714510/ https://ncbi.nlm.nih.gov/pubmed/23514733 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc12-1835 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|